Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL6) and resistant (DBA2) murine strains
- 1 July 1988
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 94 (3) , 487-495
- https://doi.org/10.1016/0041-008x(88)90289-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pharmacological studies on the in vivo cataractogenicity of acetaminophen in mice and rabbits*1Fundamental and Applied Toxicology, 1988
- Biochemical changes associated with the potentiation of acetaminophen hepatotoxicity by brief anesthesia with diethyl etherBiochemical Pharmacology, 1986
- Murine acetaminophen hepatotoxicity: Temporal interanimal variability in plasma glutamic-pyruvic transaminase profiles and relation to in vivo chemical covalent binding*1Fundamental and Applied Toxicology, 1986
- Repetitive Microvolumetric Sampling and Analysis of Acetaminophen and its Toxicologically Relevant Metabolites in Murine Plasma and Urine Using High Performance Liquid ChromatographyJournal of Analytical Toxicology, 1985
- Genetic Differences in Cataract and Other Ocular Abnormalities Induced by Paracetamol and NaphthalenePharmacology, 1980
- Ah Locus: Genetic Differences in Susceptibility to Cataracts Induced by AcetaminophenScience, 1978
- The metabolism of naphthalene and its toxic effect on the eyeBiochemical Journal, 1967